Coiled double amyloid-like fibrils allosterically catalyze hydrolysis of beta-lactam antibiotics

08 August 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The release of antibiotic compounds into wastewater constitutes a significant and growing health and environmental hazard, particularly contributing to the spread of antibiotic resistant bacterial strains. Here, we demonstrate that amyloid fibrils, consisting of an alternating lysine/phenylalanine -sheet forming short peptide, catalyze hydrolysis of β-lactam antibiotics, the most prominent family of antibiotic compounds, which is further widespread in wastewater. Peptide variant analysis, molecular dynamics (MD) simulations, and cryogenic electron microscopy (cryo-EM) reveal that the β-lactam molecules dock onto the fibrils’ surface via electrostatic interactions with the lysine sidechains. Importantly, catalytic hydrolysis occurs via an allosteric mechanism mediated by a unique coiled double fibril structure in which the anchored β-lactam molecules are embedded within twisted fiber strands, facilitating nucleophilic attacks by the lysine sidechains. Utilization of the catalytic lysine-displaying amyloid fibrils for hydrolytic degradation and removal of β-lactam antibiotics from water was accomplished through display of the fibrils on silica beads placed in a conventional column filtration setup. Amyloid fibrils displaying lysine arrays may furnish a versatile platform for hydrolysis and removal of β-lactam antibiotics in water, underscoring new avenues for addressing the considerable threat of antibiotics water contamination.

Keywords

catalytic amyloids
cross-beta amyloid fibrils
beta lactam hydrolysis

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.